A detailed history of Great West Life Assurance CO transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Great West Life Assurance CO holds 535,928 shares of TEVA stock, worth $9.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
535,928
Previous 480,299 11.58%
Holding current value
$9.37 Million
Previous $6.78 Million 28.5%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $710,938 - $967,944
55,629 Added 11.58%
535,928 $8.71 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $1.05 Million - $1.42 Million
98,710 Added 25.87%
480,299 $6.78 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $2.81 Million - $3.68 Million
-346,215 Reduced 47.57%
381,589 $3.97 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $2.78 Million - $3.97 Million
371,180 Added 104.08%
727,804 $7.42 Million
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $1.05 Million - $1.38 Million
-145,805 Reduced 29.02%
356,624 $2.69 Million
Q1 2023

May 12, 2023

BUY
$8.36 - $11.37 $37,929 - $51,585
4,537 Added 0.91%
502,429 $4.45 Million
Q4 2022

Feb 10, 2023

BUY
$7.95 - $9.48 $511,534 - $609,981
64,344 Added 14.84%
497,892 $4.56 Million
Q3 2022

Nov 01, 2022

SELL
$6.86 - $11.95 $162,767 - $283,537
-23,727 Reduced 5.19%
433,548 $3.49 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $3.37 Million - $4.76 Million
457,275 New
457,275 $3.44 Million
Q2 2022

Aug 09, 2022

SELL
$7.38 - $10.4 $3.1 Million - $4.37 Million
-420,533 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$7.33 - $9.39 $118,262 - $151,498
16,134 Added 3.99%
420,533 $4.14 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $508,491 - $655,889
64,366 Added 18.93%
404,399 $3.23 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $209,315 - $254,276
24,978 Added 7.93%
340,033 $3.34 Million
Q2 2021

Aug 11, 2021

SELL
$9.9 - $11.56 $51,272 - $59,869
-5,179 Reduced 1.62%
315,055 $3.12 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $176,896 - $219,153
17,108 Added 5.64%
320,234 $3.68 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $1.66 Million - $2.13 Million
-193,012 Reduced 38.9%
303,126 $2.92 Million
Q3 2020

Nov 17, 2020

SELL
$8.57 - $12.69 $242,265 - $358,733
-28,269 Reduced 5.39%
496,138 $4.47 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $959,814 - $1.42 Million
111,997 Added 27.16%
524,407 $4.72 Million
Q2 2020

Aug 17, 2020

SELL
$8.12 - $13.12 $315,348 - $509,528
-38,836 Reduced 8.61%
412,410 $5.07 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $474,515 - $953,995
70,929 Added 18.65%
451,246 $4.07 Million
Q4 2019

Feb 11, 2020

SELL
$6.53 - $10.72 $1.16 Million - $1.91 Million
-177,722 Reduced 31.85%
380,317 $3.73 Million
Q3 2019

Oct 25, 2019

SELL
$6.16 - $9.6 $568,223 - $885,542
-92,244 Reduced 14.19%
558,039 $3.84 Million
Q2 2019

Jul 31, 2019

BUY
$8.12 - $15.72 $525,071 - $1.02 Million
64,664 Added 11.04%
650,283 $0
Q1 2019

May 08, 2019

BUY
$15.58 - $20.01 $2.45 Million - $3.15 Million
157,429 Added 36.77%
585,619 $9.16 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $182,593 - $298,357
12,515 Added 3.01%
428,190 $6.27 Million
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $1.17 Million - $1.43 Million
-55,789 Reduced 11.83%
415,675 $8.97 Million
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $1.23 Million - $1.81 Million
73,050 Added 18.34%
471,464 $11.5 Million
Q1 2018

May 10, 2018

SELL
$16.68 - $22.07 $36,345 - $48,090
-2,179 Reduced 0.54%
398,414 $6.82 Million
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $289,734 - $492,780
25,800 Added 6.88%
400,593 $7.58 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $5.78 Million - $12.1 Million
374,793
374,793 $6.42 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.